A Rare Truncating BRCA2 Variant and Genetic Susceptibility to Upper Aerodigestive Tract Cancer
Manon Delahaye-Sourdeix(Centre international de recherche sur le cancer), James McKay(Centre international de recherche sur le cancer), Vladimír Bencko(Charles University), Thangarajan Rajkumar(Inserm), Manoj B. Mahimkar(Homi Bhabha National Institute), Jan Lubiński(Tumour Institute of Tuscany), Lorenzo Richiardi(Harvard University), Ewa Jaworowska(Cancer Genetics (United States)), Antonio Agudo(Institut Català d'Oncologia), Graham Byrnes(Centre international de recherche sur le cancer), Wolfgang Ahrens(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Ivana Holcátová(Charles University), Silvia Franceschi(Centro di Riferimento Oncologico), Letícia Fernández Garrote(Instituto de Oncología y Radiobiología), Lenka Foretová(Masaryk Memorial Cancer Institute), Amélie Chabrier(Centre international de recherche sur le cancer), Luigi Barzan(Azienda Ospedaliera Santa Maria Degli Angeli), David I. Conway(University of Glasgow), Maxime Vallée(Hospices Civils de Lyon), Valérie Gaborieau(Centre international de recherche sur le cancer), Stefania Boccia(Università Cattolica del Sacro Cuore), Marcin Lener(International Hereditary Cancer Center), Cristina Canova(University of Padua), Vladimír Janout(Palacký University Olomouc), Tatiana V. Macfarlane(University Dental Hospital of Manchester), Keitaro Matsuo(Aichi Cancer Center), Tanuja A. Samant(University of Madras), Claire M. Healy(Broad Institute), Devasena Anantharaman(Centre international de recherche sur le cancer), Nalin Thakker(University Dental Hospital of Manchester), Kristina Kjærheim(Cancer Registry of Norway), Ioan Nicolae Mateș(Carol Davila University of Medicine and Pharmacy), Maria Timofeeva(Institute of Genetics and Cancer), Jerry Polesel(Centro di Riferimento Oncologico), María Paula Curado(AC Camargo Hospital), Eleonóra Fabiánová(Public Health Authority of the Slovak Republic), Paolo Boffetta(International Prevention Research Institute), Ana Menezes(University of Utah), Sergio Koifman(Escola Nacional de Saúde Pública), Paul Brennan(Centre international de recherche sur le cancer), Xavier Castellsagué(Queen Mary University of London), Victor Wünsch-Filho(Departamento de Epidemiología), P. Lagiou(National and Kapodistrian University of Athens), David Zaridze(Russian Cancer Research Center NN Blokhin), Neonilia Szeszenia-Dabrowska(Russian Cancer Research Center NN Blokhin), Jolanta Lissowska, Ariana Znaor(University of Utah), José Eluf‐Neto(Universidade de São Paulo)
Cited by 100
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k